Purpose: To test the hypothesis: is there an association between primary open angle glaucoma (POAG) and hypothyroidism, and to establish the necessity of routine examination of thyroid function in these patients? Design: Observational cross sectional study. Materials and methods: 78 consecutive patients with a previous diagnosis of POAG and 77 control patients were evaluated for hypothyroidism. The levels of thyroid-stimulating hormone, free thyroxin and triiodothyronine were measured. Results: No patient had hypothyroidism and no correlation was found between glaucoma and either thyroid-stimulating hormone, free thyroxin or triiodothyronine. Conclusion: This study determined there is no an association between glaucoma and hypothyroidism. Therefore, we believe that the systematic screening for hypothyroidism in all patients with POAG is unnecessary.
Introduction
The literature contains contradictory studies regarding the existence of an association between hypothyroidism and primary open angle glaucoma (POAG). [1] [2] [3] [4] [5] [6] [7] Cheng and Perkins 1 reported that among patients with hypothyroidism only 2% had glaucoma. Becker and colleagues 2 studied the possible presence of myxedema of the trabecular meshwork in patients with abnormal thyroid function. Smith and colleagues 3 found that 23.4% of the patients with POAG had hypothyroidism. Safran 4 then hypothesized that there is a category of patients, who are predisposed to increased intraocular pressure (IOP) in hypothyroidism. However, Muñoz-Negrete and colleagues 5 reported that only 2.67% among patients with POAG had hypothyroidism and Karadimas and colleagues 6 in 2001 found there was no association between POAG and hypothyroidism and also no correlation between intraocular pressure before and after treatment of hypothyroidism.
However, several studies have proposed that the systematic screening for hypothyroidism should be undertaken in all patients with POAG; a costly practice. Therefore, a clinical study was designed to determine if a relationship exists between POAG and hypothyroidism.
Materials and methods
A prospective study was organized in a case control fashion. A patient pool of 155 subjects were studied. The case group consisted of 78 consecutive patients with POAG, presenting to the Glaucoma Unit of the University Hospital of Ioannina, Greece. The control group included 77 age and sex-matched healthy subjects presenting to the General Unit of the Ophthalmology Department. Patients younger than 40 years of age were excluded in both groups.
Diagnostic criteria for POAG at the time of diagnosis and for the purposes of this study were intraocular pressure 21 mmHg, measured by applanation tonometry, glaucomatous visual field defects and glaucomatous optic nerve damage. Visual fields were examined by automated perimetry (Humphrey 30-2 program; Humphrey-Zeiss, San Leandro, CA). Glaucomatous visual field defects were considered as; the presence of 2 or more adjacent points of 5 dB loss each, (as compared with the age-adjusted normal values), the presence of a single point of 10 dB loss, a difference of 5 dB across the nasal horizontal meridian at two or more adjacent points, or a Glaucoma Hemifield Test outside of the normal limits (P  0.01). Reproducibility of defects was checked by a second visual field and, in case of discrepancy, by a third. Examination of the optic disks was performed after pupil dilatation. The findings were photographically documented and reviewed by an independent reader. Signs of glaucomatous optic nerve damage were considered: the presence of local notching or thinning of the neuroretinal rim, or the presence of nerve fiber loss. During this study, within the POAG group, all patients received medical treatment for glaucoma and their intraocular pressures were 21 mmHg.
The diagnosis of hypothyroidism was based on the measurements of thyroid-stimulating hormone (TSH) obtained by immunoradiometric assay (ventrex-coated tube radioimmunoassay, high sensitivity TSH) and free thyroxin (FT 4 ). The patients were also asked for their history of thyroid disease or thyroxin replacement therapy.
The diagnosis of hypothyroidism was based on TSH values being 4.94 µIU/mL, FT 4 values  0.70 ng/dL and clinical symptoms of hypothyroidism. Symptoms of hypothyroidism included; fatigue; apathy; arthralgias; generalized slowing speech, cold intolerance, coarse dry skin, hoarse voice, constipation, headaches and weight gain. Myxedema develops secondary to the accumulation of hydrophilic mucopolysaccharides in the ground substance of the dermis, as well as other tissues, leading to thickening of the facial features and doughy induration of the skin. 9, 10 Ocular findings in hypothyroidism include ciliary alopecia, ptosis, strabismus, cataract, and nyctalopia. 11 Hypothyroidism was classified as subclinical, when TSH values were 4.94 µIU/mL, in the presence of normal serum free thyroxin (FT 4 ) (normal range 0.70-1.48 ng/dL). 9, 10 Results are given as mean ± standard deviation (SD) followed by the range of minimum-maximum values. An independent t-test and χ 2 test were used for comparison between groups. The level of statistical significance was set at P  0.05.
Results
The study included 78 patients with POAG, 40 females (51.3%) and 38 males (48.7%) with the mean age of 68.0 ± 7.35 years. The control group included 77 patients, 39 females (50.7%) and 38 males (49.3%) with a mean age of 67.28 ± 10.05 years. None of the subjects in either group reported previous thyroxin replacement therapy. The mean age and sex distribution was not significantly different in the control group (P = 0.59) (see Table 1 ). An independent t-test was used for comparison between the two groups.
Hormonal determinations were performed in both groups. The mean value of TSH was 1.19 ± 0.62 µIU/mL (range 0.03-3.6) and 1.07 ± 0.94 µIU/mL (range 0.03-7.33) in both the POAG and control groups respectively. The differences between groups were not statistically significant (P = 0.29) (see Table 1 ).
The mean value of FT 4 was 1.22 ± 0.25 ng/dL (range 0.79-1.95) and 1.22 ± 0.29 ng/dL (range 0.75-1.79) in both the POAG and control groups respectively. The differences between the groups were also not statistically significant (P = 0.89) (see Table 1 ).
The mean value of T 3 was 1.039 ± 0.20 ng/mL (range 0.735-1.338) and 1.025-0.18 ng/mL (range 0.711-1.327) in both the POAG and control groups respectively. The differences were again not statistically significant (P = 0.90) (see Table 1 ).
No glaucoma patient had TSH values  4.94 µIU/mL and only 5 patients had TSH values  0.35. We did not found any significant differences between the control and POAG groups. Two patients had FT 4  1.48 ng/dL, one in the glaucoma and one in the control group. These differences were not statistically significant between the 2 groups (Table 1) .
Moreover, no glaucoma patient and no subject of control group had FT 4 
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Only one case of subclinical hypothyroidism was detected in the control group and none in the POAG group (Table 1) .
In our study, we did not investigate any possible correlation between the IOP of the two groups with TSH, FT 4 and T 3 values because in the POAG group all patients, during this study, received medical treatment of glaucoma and their intraocular pressure were 21 mmHg.
Discussion
Hypothyroidism can be a difficult diagnosis to make because the classic symptoms can often be found in the normal elderly population. 12, 13 Bilous and Tunbridge 14 in the epidemiology of hypothyroidism stated that hypothyroidism can be found in 5% of the population, 1% as previously diagnosed and 4% newly diagnosed, with elevated TSH. In 1920 Hertel 15 reported an elevation of IOP after induced hypothyroidism in rabbits although other experimental studies failed to demonstrate these results. 16 Later McLenachan and Davies 17 in 1965 reviewed the illnesses of 100 patients with open angle glaucoma and assessed them for hypothyroidism on a clinical and biochemical basis. Thyroid abnormalities were found in 45 patients, 16 of these were said to be myxedematous. However, the analytical procedures and the diagnostic criteria of hypothyroidism and POAG used in this study were inaccurate. For this reason their study was appropriately criticized by Cheng and Perkins 1 in 1967 and the thyroid tests used in that study are now considered outdated and inaccurate when compared with modern evaluation quantifying TSH. An added criticism is that 38% of POAG patients were deemed open-angle glaucoma with elevated intraocular pressure alone. Consequently Cheng and colleagues found no association between hypothyroidism and POAG, added to this the small size of the sample (13 patients) and the fact that hypothyroid patients already received replacement therapy precludes reliable conclusions. Kruppin and colleagues 18 in 1977 also concluded that POAG was not associated with an increased prevalence of low thyroid function. Then a study by Smith and colleagues 3 in 1993 is often used to suggest that a strong relationship exists between hypothyroidism and POAG. The authors reported that hypothyroidism was present in 23.4% of patients affected with POAG. They proposed that in the hypothyroid state, hyaluronic acid accumulates in the trabecular meshwork and/or aqueous humor, causing an obstruction to intraocular drainage and that this accumulation would reverse with treatment of the hypothyroidism. Gentanni and colleagues 19 found that IOP is increased even in subclinical hypothyroid patients and that, at this early stage, the impairment is fully reversible with L-T 4 therapy. However, the diagnosis of POAG was based mainly on intraocular pressure and was not confirmed by optic disc or visual field evaluations. This fact could explain why Gentanni did not find any patients with POAG among subthyroid patients 21 in 2008, demonstrated no association between hypothyroidism and POAG. The diagnostic criteria of these entities are similar to the criteria used in the present study.
In our study we investigated the presence of clinical and subclinical hypothyroidism among patients with POAG, opting for strict definitions of hypothyroidism and glaucoma. None of the subjects in both groups (POAG and control group) had TSH values greater than 4.94 µIU/mL and FT 4 values lower than 0.70 ng/dL. Only one case of subclinical hypothyroidism was detected among healthy subjects; rates that are similar to those of the general population.
In conclusion, we have not been able to demonstrate the previously reported relationship between hypothyroidism and POAG. Therefore, despite the fact that several studies have reported contradictory results, leading to confusion as to whether the examination of thyroid function should be routine in all patients newly diagnosed with glaucoma; a rather expensive strategy. From the results of our study we cannot recommend the systematic screening in patients affected with POAG for thyroid dysfuction.
